Exclusive

Publication

Byline

Location

Clinical Trial: Tumour Immune and Ki-67 Scoring Methods as Prognostic Biomarkers in Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804173) titled 'Tumour Immune and Ki-67 Scoring Methods as Prognostic Biomarkers in Diffuse Large B-cell Ly... Read More


Singapore Clinical Trial: Evaluating the efficacy and safety of Platelet Rich Plasma for patients with Peyronie’s disease: A pilot study

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Evaluating the efficacy and safety of Platelet Rich Plasma for patients with Peyronie’s disease: A... Read More


Singapore Clinical Trial: SURFactant Administration by SUPraglottic Airway (the SURFSUP Trial)

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'SURFactant Administration by SUPraglottic Airway (the SURFSUP Trial)'. The following are the other... Read More


Singapore Clinical Trial: An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with endocrine therapy in patients with advanced hormone receptor positive, HER2-negative breast cancer and other advanced solid tumors

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with ... Read More


Singapore Clinical Trial: AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar... Read More


Singapore Clinical Trial: A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination with Trastuzumab and Chemotherapy in Participants with Metastatic HER2-Positive Breast Cancer

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination with Trastuzumab and Chemother... Read More


Singapore Clinical Trial: An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy,and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants with Heterozygous Familial Hypercholesterolemia

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy,and Pharmacokinetics of... Read More


Clinical Trial: The Effectiveness of Strength Training and Self-management in Reducing Symptoms for Individuals With Knee Osteoarthritis

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804212) titled 'The Effectiveness of Strength Training and Self-management in Reducing Symptoms for Individ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants with Advanced RCC who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Parti... Read More


Singapore Clinical Trial: A double-blind, randomized, placebo controlled pilot trial to assess the efficacy of L. reuteri in patients with Functional dyspepsia

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomized, placebo controlled pilot trial to assess the efficacy of L. reuteri in... Read More